BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO)
CUSIP: 090572207
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Class B Common Stock
- Shares outstanding
- 5,071,025
- Total 13F shares
- 19,395,139
- Share change
- -137,132
- Total reported value
- $5,876,802,288
- Put/Call ratio
- 11%
- Price per share
- $302.99
- Number of holders
- 393
- Value change
- -$33,433,698
- Number of buys
- 149
- Number of sells
- 198
Quarterly Holders Quick Answers
What is CUSIP 090572207?
CUSIP 090572207 identifies BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 090572207:
Top shareholders of BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Alice N. Schwartz |
3/4/5
13D/G
|
Director Emeritus, 10%+ Owner |
12%
from 13D/G
|
11,862,229
mixed-class rows
|
$3,592,267,092 | — | 26 Aug 2024 | |
| Steven D. Schwartz |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
8,560,438
mixed-class rows
|
$2,584,683,847 | — | 26 Aug 2024 | |
| Norman D. Schwartz |
13D/G
3/4/5
|
Chairman & CEO, Director, 10%+ Owner |
97%
|
4,929,036
|
$1,382,052,897 | $0 | 25 Sep 2025 | |
| First Eagle Investment Management, LLC |
13F
13D/G
|
Company |
11%
from 13D/G
|
2,520,319
|
$706,672,287 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group - 23-1945930 |
8.4%
from 13D/G
|
1,793,537
|
$502,889,839 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.4%
from 13D/G
|
1,695,849
|
$475,499,107 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
21%
|
1,062,938
|
$298,018,552 | — | 30 Sep 2025 | |
| Veritas Asset Management LLP |
13F
|
Company |
17%
|
844,039
|
$236,660,095 | — | 30 Sep 2025 | |
| ARIEL INVESTMENTS, LLC |
13F
|
Company |
16%
|
809,480
|
$226,970,097 | — | 30 Sep 2025 | |
| EARNEST PARTNERS LLC |
13F
|
Company |
12%
|
609,284
|
$170,837,141 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
11%
|
571,599
|
$160,270,644 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
9.1%
|
459,887
|
$128,947,715 | — | 30 Sep 2025 | |
| Capital Research Global Investors |
13F
|
Company |
8.2%
|
418,355
|
$117,302,558 | — | 30 Sep 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
7.8%
|
397,171
|
$111,362,776 | — | 30 Sep 2025 | |
| First Pacific Advisors, LP |
13F
|
Company |
7.8%
|
394,414
|
$110,589,741 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
6.9%
|
350,216
|
$98,213,875 | — | 30 Sep 2025 | |
| PARNASSUS INVESTMENTS, LLC |
13F
|
Company |
6.2%
|
315,328
|
$88,414,818 | — | 30 Sep 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
5.6%
|
282,469
|
$79,199,024 | — | 30 Sep 2025 | |
| Mawer Investment Management Ltd. |
13F
|
Company |
4.8%
|
243,468
|
$68,265,993 | — | 30 Sep 2025 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
4.7%
|
237,903
|
$66,705,645 | — | 30 Sep 2025 | |
| SOUTHEASTERN ASSET MANAGEMENT INC/TN/ |
13F
|
Company |
4.7%
|
237,254
|
$66,523,650 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
4.5%
|
230,719
|
$64,691,300 | — | 30 Sep 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
4.5%
|
226,070
|
$63,387,767 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
4.5%
|
226,006
|
$63,369,823 | — | 30 Sep 2025 | |
| THOMPSON SIEGEL & WALMSLEY LLC |
13F
|
Company |
4.3%
|
217,596
|
$61,012,000 | — | 30 Sep 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
3.6%
|
183,845
|
$51,550,000 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
3.5%
|
179,966
|
$50,460,667 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
3.5%
|
176,091
|
$49,374,000 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
—
mixed-class rows
|
174,774
mixed-class rows
|
$49,000,977 | — | 30 Sep 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
3.1%
|
155,524
|
$43,607,374 | — | 30 Sep 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
2.7%
|
134,767
|
$40,153,827 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
2.7%
|
138,889
|
$38,934,000 | — | 30 Sep 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
2.6%
|
133,465
|
$37,422,250 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
2.6%
|
133,213
|
$37,351,502 | — | 30 Sep 2025 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
2.5%
|
126,853
|
$35,568,313 | — | 30 Sep 2025 | |
| QVIDTVM Management LLC |
13F
|
Company |
2.5%
|
126,480
|
$35,463,727 | — | 30 Sep 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.5%
|
126,137
|
$35,367,553 | — | 30 Sep 2025 | |
| Gotham Asset Management, LLC |
13F
|
Company |
2.5%
|
124,626
|
$34,943,884 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.7%
|
134,927
|
$34,492,519 | — | 30 Sep 2025 | |
| Tikvah Management LLC |
13F
|
Company |
2.2%
|
111,084
|
$31,146,843 | — | 30 Sep 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
2.1%
|
107,753
|
$30,212,941 | — | 30 Sep 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
2.1%
|
107,299
|
$30,085,567 | — | 30 Sep 2025 | |
| Hound Partners, LLC |
13F
|
Company |
2.1%
|
103,963
|
$29,150,186 | — | 30 Sep 2025 | |
| Ilex Capital Partners (UK) LLP |
13F
|
Company |
2%
|
100,558
|
$28,195,458 | — | 30 Sep 2025 | |
| Boston Trust Walden Corp |
13F
|
Company |
1.9%
|
95,448
|
$26,762,665 | — | 30 Sep 2025 | |
| JNE Partners LLP |
13F
|
Company |
1.8%
|
92,100
|
$25,823,919 | — | 30 Sep 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.7%
|
86,371
|
$24,217,565 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.5%
|
75,477
|
$21,164,000 | — | 30 Sep 2025 | |
| Allianz Asset Management GmbH |
13F
|
Company |
1.3%
|
66,549
|
$18,659,674 | — | 30 Sep 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.3%
|
65,230
|
$18,290,000 | — | 30 Sep 2025 |
Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q4 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.